Logo

Pfizer Licenses Jubilant s ChemBioBase Inhibitor Databases

Mar 01, 2005

NEW YORK, March 1 (GenomeWeb News) - Pfizer has taken a global license to Jubilant Biosys' ChemBioBase gene family-specific small molecule inhibitor databases, Bangalore, India-based Jubilant said recently.

 

The databases contain published inhibitors to the kinase, GPCR, protease, ion channel, and nuclear receptor classes of targets and includes structural and functional, disease, PK/PD, and other family-specific information.

 

Financial details of the licensing agreement were not disclosed.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.